Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

FDA warns against use of troubled heart devices, citing ‘continued concerns’ after multiple recalls
The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible.
‘Concerning’ data connect industry payments to cardiologists with medical device use
U.S. physicians often receive payments from medical device manufacturers and pharmaceutical companies. New research in JAMA found a connection between receiving such payments and using specific devices—should the industry be concerned?
Cardiology groups share key update: ABMS seeking feedback on proposed Board of Cardiovascular Medicine
Five of the largest U.S. medical societies focused on cardiovascular health are one step closer to seeing their paradigm-shifting proposal become a reality.
Cardiologists, thoracic surgeons applaud FTC’s ban of most noncompete clauses
The Society for Cardiovascular Angiography & Interventions and Society of Thoracic Surgeons have both shared statements in support of the ban, which is already being challenged in court. The American Hospital Association, meanwhile, opposes the policy shift, saying it “errs by seeking to create a one-size-fits-all rule”
Q&A: Cleveland Clinic’s Lars Svensson previews AATS annual meeting
Svensson, a prominent voice in cardiothoracic surgery, said he has seen a rise in enthusiasm ahead of this year's meeting.

Private equity investors have grown more and more interested in cardiology in recent years. Roger Strode, a partner with the global law firm Foley and Lardner LLP, explains why this is.

Q&A: What the rise of private equity investments in cardiology means for cardiologists and their patients

Private equity investors have grown more and more interested in cardiology in recent years. Why the sudden shift? And what does it mean for patient care going forward?

February 15, 2023

A busy week for cardiology investments: 3 tech companies report big financing rounds

It’s not even Valentine’s Day yet, but February has already been a big month for fundraising in the cardiology space.

February 9, 2023

The long legal saga of Richard Paulus, a Kentucky cardiologist accused of performing unnecessary cardiac procedures, appears to still be going strong in 2022 and might be reviewed by the Supreme Court. The New York state radiologist is facing 36 misdemeanor counts for secret sexual recording without consent, according to a story in the Boston Herald.

Cardiologist the subject of several malpractice claims for allegedly performing unnecessary heart operations

One patient received a total of 41 stents from 2004 to 2013. He said the experience was so hard that he feared he would be driven to suicide.

December 15, 2022

Corindus, acquired back in 2019, is now Siemens Healthineers Endovascular Robotics

The company's most well-known product within the industry is the CorPath GRX System, a second-generation robotics solution used by interventional cardiologists during PCI and other interventional procedures.

December 15, 2022

Interventional cardiology to join the Match in 2025

It is an announcement many interventional cardiologists have been waiting to hear for a long time.

December 7, 2022

Emergency hospital transfer of STEMI patients might be expedited with a hospital-level 'Call 911 protocol'

The AHA Mission: Lifeline Program was designed to reduce STEMI patient transfer times, but response times still often lag, and new protocols may be needed to expedite STAT transfers.

November 15, 2022

Interventional cardiologist Deepak L. Bhatt, MD, has been named the new director of Mount Sinai Heart in New York City. He succeeds Valentin Fuster, MD, PhD, who held the position since 2006 and will now serve in a more advisory role as Mount Sinai Heart’s president.

Interventional cardiologist Deepak L. Bhatt, MD, named new director of Mount Sinai Heart

Bhatt succeeds Valentin Fuster, MD, PhD, who has held the position since 2006 and will now serve in a more advisory role at Mount Sinai Heart.

October 31, 2022

Cordis acquires MedAlliance, known for its drug-eluting balloon technology, in deal that could surpass $1B

Cordis to acquire MedAlliance, known for its drug-eluting balloons, in deal that could surpass $1B

The acquisition includes an initial investment of $35 million and an upfront closing payment of $200 million. By 2029, if the companies reach all targeted regulatory and commercial milestones, the acquisition could cost Cordis up to $1.135 billion in all.

October 25, 2022

Around the web

Cardiovascular Business

FDA announces new recall of delivery catheters after patient’s death

The recall includes specific lots of five different medical devices used to treat stroke and other neurovascular diseases.

Cardiovascular Business

FDA warns against use of troubled heart devices, citing ‘continued concerns’ after multiple recalls

The agency is urging healthcare providers to transition away from these devices and seek out alternatives. It is even working with other manufacturers to try and get similar products on the market as quickly as possible.

Cardiovascular Business

The push for an independent cardiology board continues

Jeffrey Kuvin, MD, one of the leading voices behind efforts to create a new Board of Cardiovascular Medicine, spoke with Cardiovascular Business about where things stand today.